Trials span more regions, involve more complex modalities and shift more frequently in response to enrolment patterns or protocol adjustments.
Yet the systems responsible for moving materials, information and decisions across these studies are often treated as operational plumbing rather than a strategic capability.
That view is changing, notes Sebastien Thomassin, Vice President and General Manager, Clinical Services EMEA, Thermo Fisher Scientific.
Clinical logistics now plays a central role in determining whether development programmes stay on schedule, maintain quality and respond effectively to uncertainty.
Organisations that treat logistics as a strategic discipline are gaining advantages that go beyond efficiency.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.